Deals
OpenHealth Company, a specialist in real-time healthcare data collection and analysis, has closed a EUR5 million financing round led by LBO France/Innovation Capital.
The company now plans to launch The Hub, the largest healthcare data analysis platform available in France.
OpenHealth’s Hub aggregates data from multiple sources to offer a variety of powerful capabilities for analysis.
OpenHealth believes that the analysis of healthcare data will gradually change how we understand various challenges in the healthcare sector. After massive investments in many developed countries, and especially North America, this was the first fundraising operation to be held in France
Paragon Genomics has raised USD8 million in an oversubscribed Series A funding round led by Cowin Venture Capital and Fosun Industrial Co., Limited. Additional investors were Cloudstone Venture, HEDA Ventures, and Wisemont Capital.
“With this funding, we will develop additional NGS assay products, particularly in the oncology and precision medicine space, and expand our United States commercial team. Our CleanPlex technology has been adopted by more than 50 NGS labs globally including groups from the University of California, USDA, CDC, Chinese Academy of Sciences and Annoroad Gene Technology. We are expanding our global footprint into Europe, Asia and South America
Partech Growth has invested EUR30 million investment in SendinBlue, a France-headquartered digital marketing platform for SMBs.
This Partech Growth’s eigth overall transaction and its fifth in Europe. SendinBlue will accelerate its investments in its leading one-stop-shop product and its sales and marketing efforts worldwide.
Armand Thiberge, CEO and founder of SendinBlue, says: “Choosing Partech was obvious to us. In addition to its strong international and technological dimension, Partech represents an expertise and network unmatched in Europe. Their recipe can be summarised as follows: commitment, support to entrepreneurs, and intelligence.”
Partech’s EUR400 million growth fund was launched in January
After a rigorous global process and rounds of technical and qualitative reviews, Fintech71 has officially chosen its inaugural cohort of financial technology startups.
The ten startups were formally announced today at Finovate in New York City. Three European companies, from the UK, Ireland and Portugal, are among the ten winners.
London-based Billion Group has been named one of the fintechs in the first cohort, in recognition of its groundbreaking platform for financial transactions using distributed ledger to exchange regulated currencies.
The announcement coincides with more corporate partners declaring support for the effort. In the last few weeks, Accenture,
Monroe Capital has acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the growth of Citizens Rx.
Based in Oak Park, Illinois, Citizens Rx is a full-service Pharmacy Benefit Management provider for public and private companies and health plans. The company provides “unbundled,” modular pharmacy benefit management services, including formulary management, claims processing, rebate administration, and a 67,000-location national pharmacy network.
Atlas for Men, the men’s outdoor clothing brand that became independent from Groupe De Agostini a year ago, following a spin-off organized by Activa Capital and the Management team, has refinanced its existing debt alongside an extended pool of banks, allowing the full reimbursement of the mezzanine debt and partial reimbursement of the shareholder funds.
Founded in 1999 within the Groupe De Agostini, Atlas for Men is a specialized men’s outdoor brand for clothing and accessories, sold online and by catalogue. The brand is present in 10 European countries and generates close to EUR160 million in sales from six million
Foresight Group (Foresight) has invested GBP3 million from the Foresight Regional Investment Fund into the specialist engineering company ONFAB Limited, a designer and manufacturer of flexible containment solutions, primarily for use in pharmaceutical manufacturing processes.
ONFAB was founded in 2004 by Oliver Nulty, a former Astra Zeneca engineer, who spotted the market opportunity created by increasing health and safety regulations which made containment a higher priority, specifically in pharmaceutical manufacturing processes. Today, the total global containment market is valued at around GBP320m, with an estimated growth rate of 10-20 per cent per annum.
With Foresight’s investment, ONFAB will continue
Pegasus Solar, a designer and manufacturer of innovative rooftop mounting systems for solar installations, has closed on a Series A round of equity funding led by Ecosystem Integrity Fund (EIF), with additional participation from Okapi Capital, Howard Wenger, Mike Miskovsky, and other solar industry executives.
Pegasus said that it will use the proceeds to grow its sales and customer support teams and to continue its industry-leading efforts to design and manufacture efficient and functional solar mounting systems.
“We are excited to partner with EIF and other investors who share our passion for solar energy and support our mission to
Private equity firm Silverfleet Capital is to acquire Pumpenfabrik Wangen (Wangen), a designer and manufacturer of high quality progressing cavity and twin-screw pumps.
Silverfleet will acquire a majority stake from the Company’s individual private shareholders. Completion is subject to regulatory approval and the terms of the transaction were not disclosed.
Founded in 1969 and based in Wangen, Germany, the Company is a market leader in the manufacture of screw pumps that are suitable for highly viscous or abrasive substances as well as solid-fluid composites. Wangen offers a broad range of standard as well as customised pumps designed and manufactured
InfoSum has added USD5 million to its seed funding, taking the total raised to date to USD8 million.
Joining existing investors Mark Suster (Upfront Ventures) and Roger Ehrenberg (IA Ventures), are Saul Klein (LocalGlobe), and Mike Chalfen (Mosaic Ventures). The additional investment will be used to build the company’s senior management team and bring the company’s first products to market.
InfoSum’s goal is to equip every company with the ability to unlock the commercial potential of thousands of siloed datasets sitting in numerous companies. In doing so it will give every organisation access to the same breadth and depth
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
